TABLE 3.
Per-Vessel Analysis of Coronary 18F-Fluoride Activity over 12 Months
| 3 mo | 6 mo | 12 mo | |||||
|---|---|---|---|---|---|---|---|
| Parameter | Total | Negative | Positive | Negative | Positive | Negative | Positive |
| All participants | 330 | ||||||
| Baseline CMA | |||||||
| Negative (CMA = 0) | 193/330 (58%) | 44/93 (47%) | 6/93 (6%) | 58/120 (48%) | 9//120 (8%) | 69/117 (59%) | 7/117 (6%) |
| Positive (CMA > 0) | 137/330 (42%) | 13/93 (14%) | 30/93 (32%) | 11/120 (9%) | 42/120 (35%) | 13/117 (11%) | 28/117 (24%) |
| Recent acute myocardial infarction | 156 | ||||||
| Negative (CMA = 0) | 110/156 (71%) | 17/36 (47%) | 6/36 (17%) | 32/60 (53%) | 7/60 (12%) | 44/60 (73%) | 4/60 (7%) |
| Positive (CMA > 0) | 46/156 (29%) | 6/36 (17%) | 7/36 (19%) | 4/60 (7%) | 17/60 (28%) | 3/60 (5%) | 9/60 (15%) |
| Advanced chronic coronary artery disease | 174 | ||||||
| Negative (CMA = 0) | 83/174 (48%) | 27/57 (47%) | 0/57 (0%) | 26/60 (43%) | 2/60 (3%) | 25/57 (44%) | 3/57 (5%) |
| Positive (CMA > 0) | 91/174 (52%) | 7/57 (12%) | 23/57 (40%) | 7/60 (12%) | 25/60 (42%) | 10/57 (18%) | 19/57 (33%) |